Sort by 
Record Exports, Record Jobs: How Ireland's Pharma Sector Is Redefining National Economic Power
Ireland's pharma sector hit record highs in 2025 for exports, employment and tax receipts. As GLP-1 drug demand surges, the industry's role as Ireland's economic backbone has never been stronger.
Skyhawk Therapeutics appoints Teva veteran Aaron Deves to lead Huntington's disease drug commercialisation
US-based clinical-stage biotech Skyhawk Therapeutics has appointed Aaron Deves as chief commercial officer to lead the commercialisation of SKY-0515 for Huntington's disease. Deves brings over 30 years of neurological drug commercialisation experience.
CF and Medlior join forces to advance cross-border life sciences evidence for UK and Canadian markets
UK consultancy CF has partnered with Canadian firm Medlior Health Outcomes Research to generate real-world evidence for global life science sponsors. The alliance spans NHS England and Alberta datasets.
LifeCellsNI secures £590,000 to establish Northern Ireland's first regulated stem cell biobank in Derry
Derry-based start-up LifeCellsNI has raised £590,000 (€689,000) to build Northern Ireland's first HTA-licensed stem cell storage and biobank facility. Cleanroom installation is under way ahead of an April launch.
Cirdan Imaging targets global expansion with £12.9m investment and 72 new jobs in Northern Ireland
Northern Ireland-based medical imaging firm Cirdan Imaging is creating 72 new jobs in a £12.9m (€15.1m) investment to expand its laboratory information system. Invest NI has offered £1.9m in support towards the initiative.
Athlone Laboratories puts Ireland's critical medicines manufacturing capacity in the spotlight
Irish contract manufacturer Athlone Laboratories has reaffirmed its role in Europe's critical medicines supply chain, with annual capacity to produce 1.2 billion oral Beta-lactam dosage forms. The firm manufactures the antibiotic class at its Irish site for over 40 years.
Sonas Pharma closes pre-seed round for neurological disorder research
Omagh-based biotechnology start-up Sonas Pharma has completed a pre-seed investment round to progress obesity and epilepsy treatment research. The funding advances Northern Ireland's pharmaceutical manufacturing excellence sector through endocannabinoid system therapeutic development.
Pharma Industry Awards UK 2026 will open entries to honour sector excellence
The Pharma Industry Awards UK 2026 will open for entries on 16 March 2026, inviting pharmaceutical organisations, teams, and leaders to showcase their achievements in innovation, manufacturing, R&D, sustainability, and digital transformation. This premier platform honours excellence across the UK's pharmaceutical sector. Entries will close on 5 June 2026, with finalists to be announced on 23 July and winners celebrated at the Park Plaza London Riverbank on 23 September 2026. Register now to gain national recognition and connect with the industry's most influential players.
Sinopia Biosciences collaborates with Ono Pharmaceutical on rare metabolic disorder targets
Sinopia Biosciences has announced a target discovery collaboration with Ono Pharmaceutical for rare metabolic disorders. The partnership strengthens pharmaceutical manufacturing excellence capabilities through metabolomics-driven drug discovery and artificial intelligence methodologies.
Eli Lilly commits $500 million to South Korea biopharma innovation
United States-based Eli Lilly has pledged $500 million (€423 million) over five years to South Korea's biopharma industry. The investment strengthens pharmaceutical manufacturing excellence capabilities through clinical trials and an innovation incubator.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
